NEW YORK (GenomeWeb) – Optivia Biotechnologies and cell-based assays firm Hurel today announced they have reached a technology and marketing alliance..

The partnership will give researchers an array of powerful tools for in vitro studies of hepatic clearance and drug-induced liver injury, the firms said in a statement.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

In Science this week: International Wheat Genome Sequencing Consortium publishes the bread wheat cultivar Chinese Spring reference genome, and more.

At his FDA Law Blog, Jeffrey Gibbs discusses FDA's technical assistance for the draft Diagnostic Accuracy and Innovation Act.

The New York Times reports that genetic testing has uncovered unfaithful penguins at a Utah aquarium.

Cancer researcher loses funding under new Wellcome Trust anti-bullying policies, the Guardian reports.